Search results for "renal insufficiency"

showing 10 items of 175 documents

CT-guided nephrostomy–An expedient tool for complex clinical scenarios

2018

Abstract Introduction & objectives Percutaneous nephrostomy [ 1 ] has emerged as a pivotal approach in the therapeutic management of the obstructed urinary tract. A consecutive incorporation of ultrasonic and radiographic guidance, the approach experienced an almost ubiquitious distribution while most centers currently applying either one or both of these tools jointly. However, success of ultrasound-guidance is limited in obese patients and non-dilated uropathy. In turn, fluoroscopy usually requires an opacification of the urinary collecting system by intravenous or antegrade contrast media injection, which might be harmful for already impaired renal function, raise intrapelvic pressure an…

MaleUrologic Diseasesmedicine.medical_specialtySupine positionUrinary systemmedicine.medical_treatmentKidneyRadiography Interventional030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineUrethral DiseasesmedicineHumansRadiology Nuclear Medicine and imagingObesityRenal InsufficiencyObstructive uropathyUltrasonography InterventionalAgedNephrostomy PercutaneousRetrospective Studiesbusiness.industryMortality rateGeneral MedicineOverweightmedicine.diseaseSurgeryProne positionSurgery Computer-AssistedPercutaneous nephrostomyFluoroscopy030220 oncology & carcinogenesisFeasibility StudiesFemaleMedian bodyTomography X-Ray ComputedbusinessComplicationAnesthesia LocalDilatation PathologicEuropean Journal of Radiology
researchProduct

Dialysis vintage time has the strongest correlation to psychosocial pattern of oral health-related quality of life – a multicentre cross-sectional st…

2018

Background Aim of this cross-sectional, multicentre study was to investigate associations of dialysis vintage time in haemodialysis (CKD5D) patients with oral health-related quality of life (OHRQoL) and dental and periodontal treatment need. Material and Methods CKD5D patients were divided into subgroups according to dialysis vintage time in different dialysis centres in Germany. OHRQoL was assessed with oral health impact profile (OHIP-G14). Dental treatment need was classified as presence of carious lesions. Periodontal treatment need was defined as periodontal screening index score (PSI) 3-4. Results In total, 190 participants were divided into the subgroups according to the time on CKD5…

MaleVintagemedicine.medical_specialtyTime FactorsCross-sectional studymedicine.medical_treatment030232 urology & nephrologyOral HealthOral healthCorrelation03 medical and health sciences0302 clinical medicineQuality of lifeRenal DialysisInternal medicinemedicineHumansRenal Insufficiency ChronicCorrelation of DataGeneral DentistryDialysisAgedbusiness.industryResearch030206 dentistryMiddle AgedMedically compromised patients in Dentistry:CIENCIAS MÉDICAS [UNESCO]humanitiesstomatognathic diseasesCross-Sectional StudiesOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASCohortQuality of LifeFemaleSurgerybusinessPsychosocialMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Acute renal insufficiency and pancreatitis in a child with atypical Henoch–Schönlein purpura: efficacy of a single dose of cyclophosphamide

2018

A 9-year-old boy with petechiae on the legs and abdominal pain was unsuccessfully treated with steroids. He was admitted to our hospital for the onset of fever, ecchymosis, and arthralgia. Skin lesions suggested vasculitis, but they were not typical of Henoch–Schönlein purpura. He showed ecchymosis of the scrotal bursa, diffusion of petechiae to the trunk and arms, vomiting, severe abdominal pain, oliguria with hyponatremia, hypoalbuminemia, low C3 levels, high levels of creatinine, blood urea nitrogen, and tubular enzymes, proteinuria, and glycosuria. The urinary sediment showed macrohaematuria, and hyaline and cellular casts. Ultrasound showed polyserositis. He was treated with intraveno…

MalecorticosteroidMedicine (General)medicine.medical_specialtyAbdominal painHenoch-Schonlein purpuraIgA VasculitisEcchymosisAnti-Inflammatory Agentspancreatitisskin lesionCase ReportsMethylprednisoloneBiochemistryGastroenterology03 medical and health sciencesR5-9200302 clinical medicinehemic and lymphatic diseases030225 pediatricsInternal medicinemedicineHumansChildbusiness.industryBiochemistry (medical)pancreatitiAcute renal insufficiencyCell BiologyGeneral MedicineAcute Kidney InjuryPrognosismedicine.diseasePurpuraMethylprednisolonePancreatitisAcute pancreatitisDrug Therapy Combinationcyclophosphamide030211 gastroenterology & hepatologymedicine.symptomHenoch–Schönlein purpuraHyponatremiabusinessImmunosuppressive Agentsmedicine.drugJournal of International Medical Research
researchProduct

CA125-Guided Diuretic Treatment Versus Usual Care in Patients With Acute Heart Failure and Renal Dysfunction

2020

BACKGROUND: The optimal diuretic treatment strategy for patients with acute heart failure and renal dysfunction remains unclear. Plasma carbohydrate antigen 125 (CA125) is a surrogate of fluid overload and a potentially valuable tool for guiding decongestion therapy. The aim of this study was to determine if a CA125-guided diuretic strategy is superior to usual care in terms of short-term renal function in patients with acute heart failure and renal dysfunction at presentation. METHODS: This multicenter, open-label study randomized 160 patients with acute heart failure and renal dysfunction into 2 groups (1:1). Loop diuretics doses were established according to CA125 levels in the CA125-gui…

Maleendocrine system diseasesPREDICTIONmedicine.medical_treatmentUrine030204 cardiovascular system & hematologyKidney Function TestsCONGESTIONBiomarker guided-therapy0302 clinical medicineSodium Potassium Chloride Symporter InhibitorsFurosemideNatriuretic peptideMedicineRenal Insufficiency030212 general & internal medicinePrecision MedicineANTIGEN CARBOHYDRATE 125Aged 80 and overFurosemideGeneral MedicineDiuretic treatmentEUROPEAN-SOCIETYClinical trialFemaleTRIALmedicine.drugmedicine.medical_specialtyRenal failureSTRATEGIESmedicine.drug_classUrologyRenal function03 medical and health sciencesHumansIn patientAgedHeart FailureSERUM CREATININENATRIURETIC PEPTIDEbusiness.industryMORTALITYMembrane ProteinsAcute heart failuremedicine.diseaseClinical trialCarbohydrate antigen 125CA-125 AntigenHeart failureDiuretic treatmentDiureticbusinessCARDIORENAL SYNDROME
researchProduct

Cost of Type 2 Diabetes Patients with Chronic Kidney Disease Based on Real-World Data: An Observational Population-Based Study in Spain

2021

[EN] This study analyzed the prevalence, costs and economic impact of chronic kidney disease CKD in patients with T2D in a Spanish Health District using real-world data. Observational cross-sectional study in adult patients with T2D was through data extracted from the information systems of the Valencia Clinico-La Malvarrosa Health District in the year 2015. Patients were stratified with the KDIGO classification for CKD. Additionally, patients were assigned to Clinical Risk Groups (CRGs) according to multimorbidity. Direct costs of primary and specialized care, and medication were estimated. The prevalence of T2D in the database population (n = 28,345) was 10.8% (mean age (SD) = 67.8 years …

Malehealthcare resourcesmedicine.medical_specialtyECONOMIA APLICADAHealth Toxicology and MutagenesisPopulationRenal functioncostsType 2 diabetesDiseaseArticleIndirect costsChronic kidney diseaseInternal medicineHealth caremedicineHumansRenal Insufficiency ChronicHealthcare resourcesBurden of careeducationAgededucation.field_of_studyDiabetisbusiness.industryClinical Risk GroupsPublic Health Environmental and Occupational HealthRType 2 diabetesHealth Care Costsmedicine.diseaseCostsKDIGO classificationCross-Sectional StudiesDiabetes Mellitus Type 2Spainburden of careInsuficiència renal crònicaMedicineFemaleObservational studyECONOMIA FINANCIERA Y CONTABILIDADtype 2 diabetesbusinesschronic kidney diseaseKidney diseaseInternational Journal of Environmental Research and Public Health
researchProduct

Incidence of Kidney Replacement Therapy and Subsequent Outcomes Among Patients With Systemic Lupus Erythematosus: Findings From the ERA Registry.

2022

RATIONALE AND OBJECTIVE: There is a dearth of data characterizing patients requiring kidney replacement therapy (KRT) for kidney failure due to systemic lupus erythematosus (SLE) and their clinical outcomes. The aim of this study was to describe trends in incidence and prevalence of KRT among these patients as well as to compare their outcomes to patients treated with KRT for diseases other than SLE.STUDY DESIGN: Retrospective cohort study based on kidney registry data.SETTING & PARTICIPANTS: Patients recorded in 14 registries of patients receiving kidney replacement therapy that provided data to the European Renal Association (ERA) Registry between 1992 and 2016.PREDICTOR: SLE as cause…

Malekidney diseasemedicine.medical_treatmentMAINTENANCE DIALYSIS030232 urology & nephrologyLupus nephritislupus nephritis (LN)0302 clinical medicineLupus Erythematosus Systemickidney replacement therapy (KRT)RegistriesRenal InsufficiencyKidney transplantationRISKeducation.field_of_studyKidneyregistry studyIncidence (epidemiology)IncidenceSTAGE RENAL-DISEASELupus Nephritis3. Good healthEuropeRenal Replacement Therapymedicine.anatomical_structureNephrologySURVIVALFemalemedicine.medical_specialtyprevalencePopulationkidney transplantationUNITED-STATESsurvival03 medical and health sciencesAFRICAN-AMERICAN PATIENTSInternal medicinemedicineHumansESRDeducationNEPHRITISDialysisRetrospective Studies030203 arthritis & rheumatologyProportional hazards modelbusiness.industryTRANSPLANTATIONMORTALITYRetrospective cohort studymedicine.diseasekidney failureend-stage renal disease (ESRD)3121 General medicine internal medicine and other clinical medicineSystemic lupus erythematosus (SLE)Kidney Failure ChronicprognosisbusinessAmerican journal of kidney diseases : the official journal of the National Kidney Foundation
researchProduct

Impact of COVID-19 Pandemic in Children with CKD or Immunosuppression

2021

Infections are a major concern in children on KRT and with CKD. Risk factors include immunosuppression, multiple contacts in dialysis units, and hospital visits ([1][1]). Italy was one of the countries most affected by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak ([2][2

Malemedicine.medical_specialty2019-20 coronavirus outbreakAdolescentCoronavirus disease 2019 (COVID-19)EpidemiologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)medicine.medical_treatmentglomerular disease030232 urology & nephrologyComorbidity030204 cardiovascular system & hematologyCritical Care and Intensive Care MedicineRisk Assessmentchronic kidney disease; COVID-19; immunosuppression; kidney transplantation; glomerular disease; childrenImmunocompromised Host03 medical and health sciences0302 clinical medicinechildrenRenal DialysisRisk FactorsInternal medicinePandemicHumansMedicineRenal Insufficiency ChronicChildCOVID-19; children; chronic kidney disease; glomerular disease; immunosuppression; kidney transplantation; Adolescent; Age Factors; Child; Child Preschool; Comorbidity; Female; Humans; Infant; Italy; Kidney Transplantation; Male; Renal Dialysis; Renal Insufficiency Chronic; Risk Assessment; Risk Factors; COVID-19; Immunocompromised HostKidney transplantationTransplantationimmunosuppressionbusiness.industryAge FactorsCOVID-19InfantOutbreakImmunosuppressionmedicine.diseaseKidney TransplantationResearch LettersItalyNephrologyChild PreschoolDialysis unitFemalebusinesschronic kidney diseaseClinical Journal of the American Society of Nephrology
researchProduct

Contrast-induced Nephropathy after Percutaneous Coronary Intervention in Simple Lesions: Risk Factors and Incidence are Affected by the Definition Ut…

2011

Aim To compare the incidence, and risk factors, in-hospital and at the 18-month prognosis of contrast-induced nephropathy (CIN) according to the definition utilized: as an increase in serum creatinine (Scr) ≥0.5 mg/dL (CIN 1) or as an increase in Scr ≥25% above baseline values (CIN 2). Methods and Results We prospectively evaluated CIN according to two different definitions in 150 patients who underwent percutaneous coronary intervention (PCI) in simple lesions employing a low-medium dose of contrast media. Incidence of CIN was higher using the CIN 2 definition than CIN 1 (9.3% vs. 4%; p=0.0133). Patients with CIN 1 had a higher incidence of chronic kidney disease (CKD) (66.7% vs. 13.9%; p=…

Malemedicine.medical_specialtyAnemiamedicine.medical_treatmentContrast-induced nephropathyUrologyContrast MediaRenal functionurologic and male genital diseasesPercutaneous coronary interventionNephropathychemistry.chemical_compoundContrast induced nephropathyRisk FactorsInternal MedicinemedicineHumansProspective StudiesAngioplasty Balloon CoronaryRenal Insufficiency ChronicneoplasmsAgedCreatininecontrast induced nephropathy percutaneous coronary interventionbusiness.industryIncidenceIncidence (epidemiology)virus diseasesPercutaneous coronary interventionAnemiaGeneral MedicineMiddle Agedmedicine.diseasefemale genital diseases and pregnancy complicationsSurgerysurgical procedures operativeItalychemistryCreatinineFemaleKidney DiseasesbusinessKidney diseaseInternal Medicine
researchProduct

Cardiac Troponins for the Diagnosis of Acute Myocardial Infarction in Chronic Kidney Disease

2018

Background Patients with chronic kidney disease ( CKD ) are at high risk of myocardial infarction. Cardiac troponins are the biomarkers of choice for the diagnosis of acute myocardial infarction ( AMI ) without ST ‐segment elevation ( NSTE ). In patients with CKD , troponin levels are often chronically elevated, which reduces their diagnostic utility when NSTE ‐ AMI is suspected. The aim of this study was to derive a diagnostic algorithm for serial troponin measurements in patients with CKD and suspected NSTE ‐ AMI . Methods and Results Two cohorts, 1494 patients from a prospective cohort study with high‐sensitivity troponin I (hs‐ cTnI ) measurements and 7059 cases from a clinical registr…

Malemedicine.medical_specialtyCardiac troponinNephrology and KidneyMyocardial InfarctionDiagnostic Testingmacromolecular substances030204 cardiovascular system & hematologynon‐ST‐segment elevation acute coronary syndromeurologic and male genital diseases03 medical and health sciences0302 clinical medicineTroponin TInternal medicinecohort studymedicineHumansProspective Studiescardiovascular diseasesddc:610030212 general & internal medicineMyocardial infarctionRenal Insufficiency ChronicOriginal ResearchAgedKidney in Cardiovascular Diseasebusiness.industryTroponin IMiddle AgedPrognosismedicine.diseasefemale genital diseases and pregnancy complicationsdecision aidsCardiologybiomarkerBiomarker (medicine)FemaleCardiology and Cardiovascular MedicinebusinessAcute Coronary Syndromeschronic kidney diseaseBiomarkersFollow-Up StudiesGlomerular Filtration RateKidney diseaseCohort studyJournal of the American Heart Association
researchProduct

Prevalence of renal failure and use of antithrombotic prophylaxis among medical inpatients at increased risk of venous thromboembolic events.

2007

Abstract Background Evidence-based guidelines recommend the use of antithrombotic prophylaxis in medical patients at risk of venous thromboembolism (VTE). Low molecular weight heparins (LMWHs) are usually preferred to unfractionated heparin. However, when prophylactic doses of LMWH are administered, patients with renal failure (RF) are exposed to the risk of excessive accumulation, and thus to an increased risk of bleeding. We aimed to assess the prevalence of RF among medical inpatients at increased risk of VTE and the use and dosage of antithrombotic prophylaxis in these patients. Methods In a cross sectional study carried out at three different hospitals, information on all medical inpat…

Malemedicine.medical_specialtyCross-sectional studyAntithrombotic treatmentFibrinolytic AgentsInternal medicineAntithromboticmedicinePrevalenceHumansProspective StudiesRenal InsufficiencyMedical prescriptionIntensive care medicineAgedbusiness.industryHematologyHeparinVenous ThromboembolismHeparin Low-Molecular-WeightMiddle AgedIncreased riskCross-Sectional StudiesFemalebusinessVenous thromboembolismmedicine.drug
researchProduct